Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001683168-21-006069
Filing Date
2021-12-02
Accepted
2021-12-02 16:30:07
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL INFORMATION xenetic_defa.htm DEFA14A 34762
2 GRAPHIC image_001.jpg GRAPHIC 54199
3 GRAPHIC image_002.jpg GRAPHIC 132030
4 GRAPHIC image_003.jpg GRAPHIC 102957
  Complete submission text file 0001683168-21-006069.txt   434586
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37937 | Film No.: 211466971
SIC: 2834 Pharmaceutical Preparations